Protalix BioTherapeutics (PLX) Selling, General & Administrative (2010 - 2026)
Protalix BioTherapeutics' Selling, General & Administrative came in at $3.11 million for Q2 2026, up 18.6% from $2.62 million a year earlier and up 2.0% from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Protalix BioTherapeutics reported Selling, General & Administrative of $12.62 million, up 16.6% year-over-year; for FY2025, it was $11.68 million, down 4.2% from FY2024.
- Selling, General & Administrative carries a five-year compound annual growth rate of 0.9% (FY2020 to FY2025).
- Going back by year, Selling, General & Administrative was $12.19 million in FY2024 (-18.5%), $14.96 million in FY2023 (+27.7%), $11.71 million in FY2022 (-8.0%) and $12.73 million in FY2021 (+14.2%).
- The five-year range for quarterly Selling, General & Administrative is $2.6 million (Q3 2024) to $4.14 million (Q4 2023).
- Year-over-year, Selling, General & Administrative has increased for four consecutive quarters, with an average decline of 4.0% over the last eight quarters.
- The fastest year-over-year change in Selling, General & Administrative over five years came in Q2 2023 (growth of 54.4%), and the weakest in Q3 2024 (a decline of 29.3%).
- Business Quant data shows PLX's Selling, General & Administrative at $3.05 million (Q1 2026), $3.53 million (Q4 2025) and $2.93 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Protalix BioTherapeutics | 207.07 Mn | 55.69 Mn | 12.13 Mn | 3.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.11 Mn |
| Mar 31, 2026 | 3.05 Mn |
| Dec 31, 2025 | 3.53 Mn |
| Sep 30, 2025 | 2.93 Mn |
| Jun 30, 2025 | 2.62 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Sep 30, 2024 | 2.60 Mn |
| Jun 30, 2024 | 3.48 Mn |
| Mar 31, 2024 | 3.12 Mn |
| Dec 31, 2023 | 4.14 Mn |
| Sep 30, 2023 | 3.67 Mn |
| Jun 30, 2023 | 4.03 Mn |
| Mar 31, 2023 | 3.12 Mn |
| Dec 31, 2022 | 3.10 Mn |
| Sep 30, 2022 | 2.85 Mn |
| Jun 30, 2022 | 2.61 Mn |
| Mar 31, 2022 | 3.15 Mn |
| Dec 31, 2021 | 3.47 Mn |
| Sep 30, 2021 | 2.95 Mn |
API Access
Protalix BioTherapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();